> Spin-offs 2011
The Spin-off Panel enables potential investors, partners or licensees to learn about additional, comparatively advanced projects and encourages entrepreneurs to present their businesses in a way that appeals to experienced decision makers from the biopharmaceutical industry. It will combine a challenging question time with one-slide and poster presentations.
Dr Ulrich Rant, Dr Dirk Scholl
Wolfram Teetz, Dr Igor Tetko, Ahmed Abdelaziz
Lars Krüger, Dr Gerd-Uwe Flechsig
Dr Werner Zuschratter, Yury Prokazov
Prof. Uwe Jacob, Prof. Georg Fey